Definitive Contract 75N91023C00051
Award Date
9/18/23
Potential Completion Date
9/17/25
Potential Value
$2M
Federal Agency
National Cancer Institute
Awardee
Carina Medical LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Ashburn, VA 20148, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $455,000 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Carina Medical LLC, a minority-owned small business. The contract supports research and development of artificial intelligence (AI)-aided imaging technologies for cancer prevention, diagnosis, and monitoring. This work aligns with the NCI's mission and the SBIR program's goals of stimulating...
This $455,000 firm fixed price contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Carina Medical LLC, a minority-owned small business. The contract, set aside for small businesses, is for the development of software to evaluate artificial intelligence/machine learning medical devices in oncology settings. Carina Medical has a history of federal contracts and grants from the NCI and NIH, totaling over $8 million, to advance...
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1.5 million delivery order contract to Leidos Biomedical Research Inc. to provide manufacturing of tumor-penetrating microparticles suitable for human use. The contract runs from September 15, 2023 through September 14, 2028 and utilizes a cost plus fixed fee pricing structure. Performance will take place in Fort Detrick, Maryland. No applicable subcontractors were identified.</p>
This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Phenomapper, LLC, a minority-owned, self-certified small disadvantaged business located in San Jose, California. The $398,952.00 firm-fixed-price contract was awarded on September 16, 2020, with a completion date of September 15, 2021. The contract is for the development of artificial intelligence-aided imaging technology...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $354,415.00 Firm Fixed Price contract to Oncospace Inc., a Baltimore-based small business, to develop artificial intelligence (AI) tools to understand and duplicate expert radiation therapy planning for prostate cancer. This contract is part of the Small Business Innovation Research (SBIR) program and builds upon prior SBIR and National Science Foundation awards to Oncospace Inc....